Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1977 2
1978 3
1980 1
1981 1
1982 2
1983 5
1984 2
1985 8
1986 19
1987 17
1988 22
1989 21
1990 23
1991 21
1992 26
1993 11
1994 19
1995 16
1996 22
1997 19
1998 12
1999 12
2000 33
2001 23
2002 27
2003 37
2004 36
2005 33
2006 23
2007 19
2008 33
2009 53
2010 67
2011 60
2012 54
2013 64
2014 81
2015 89
2016 92
2017 107
2018 114
2019 118
2020 113
2021 148
2022 152
2023 187
2024 165

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,003 results

Results by year

Filters applied: . Clear all
Page 1
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Litchfield K, Reading JL, Puttick C, Thakkar K, Abbosh C, Bentham R, Watkins TBK, Rosenthal R, Biswas D, Rowan A, Lim E, Al Bakir M, Turati V, Guerra-Assunção JA, Conde L, Furness AJS, Saini SK, Hadrup SR, Herrero J, Lee SH, Van Loo P, Enver T, Larkin J, Hellmann MD, Turajlic S, Quezada SA, McGranahan N, Swanton C. Litchfield K, et al. Among authors: saini sk. Cell. 2021 Feb 4;184(3):596-614.e14. doi: 10.1016/j.cell.2021.01.002. Epub 2021 Jan 27. Cell. 2021. PMID: 33508232 Free PMC article.
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
Maurer M, Casale TB, Saini SS, Ben-Shoshan M, Giménez-Arnau AM, Bernstein JA, Yagami A, Stjepanovic A, Radin A, Staudinger HW, Patel N, Amin N, Akinlade B, Fan C, Bauer D, Yancopoulos GD, Patel K, Mannent LP, Laws E. Maurer M, et al. Among authors: saini ss. J Allergy Clin Immunol. 2024 Jul;154(1):184-194. doi: 10.1016/j.jaci.2024.01.028. Epub 2024 Feb 29. J Allergy Clin Immunol. 2024. PMID: 38431226 Free article. Clinical Trial.
Designed proteins assemble antibodies into modular nanocages.
Divine R, Dang HV, Ueda G, Fallas JA, Vulovic I, Sheffler W, Saini S, Zhao YT, Raj IX, Morawski PA, Jennewein MF, Homad LJ, Wan YH, Tooley MR, Seeger F, Etemadi A, Fahning ML, Lazarovits J, Roederer A, Walls AC, Stewart L, Mazloomi M, King NP, Campbell DJ, McGuire AT, Stamatatos L, Ruohola-Baker H, Mathieu J, Veesler D, Baker D. Divine R, et al. Among authors: saini s. Science. 2021 Apr 2;372(6537):eabd9994. doi: 10.1126/science.abd9994. Science. 2021. PMID: 33795432 Free PMC article.
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT, Watkins TB, Shafi S, Murugaesu N, Mitter R, Akarca AU, Linares J, Marafioti T, Henry JY, Van Allen EM, Miao D, Schilling B, Schadendorf D, Garraway LA, Makarov V, Rizvi NA, Snyder A, Hellmann MD, Merghoub T, Wolchok JD, Shukla SA, Wu CJ, Peggs KS, Chan TA, Hadrup SR, Quezada SA, Swanton C. McGranahan N, et al. Among authors: saini sk. Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3. Science. 2016. PMID: 26940869 Free PMC article.
Authors' response.
Kaur S, Singh A, Saini S, Rohilla L, Kaur J, Chandi A, Kaur G, Singh M, Kumar P, Soni SL, Kajal K, Naik NB, Malhotra P, Verma S, Gupta M, Devnani M, Das K, Pandav SS, Puri GD. Kaur S, et al. Among authors: saini s. Indian J Med Res. 2022 May-Jun;155(5&6):591. doi: 10.4103/0971-5916.359153. Indian J Med Res. 2022. PMID: 36348603 Free PMC article. No abstract available.
Urticaria and basophils.
Saini SS. Saini SS. Allergol Int. 2023 Jul;72(3):369-374. doi: 10.1016/j.alit.2023.05.001. Epub 2023 May 21. Allergol Int. 2023. PMID: 37221123 Free article. Review.
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
Saini SS, Bindslev-Jensen C, Maurer M, Grob JJ, Bülbül Baskan E, Bradley MS, Canvin J, Rahmaoui A, Georgiou P, Alpan O, Spector S, Rosén K. Saini SS, et al. J Invest Dermatol. 2015 Jan;135(1):67-75. doi: 10.1038/jid.2014.306. Epub 2014 Jul 21. J Invest Dermatol. 2015. PMID: 25046337 Free PMC article. Clinical Trial.
Pediatric Inner-City Asthma.
Seth D, Saini S, Poowuttikul P. Seth D, et al. Among authors: saini s. Immunol Allergy Clin North Am. 2021 Nov;41(4):599-611. doi: 10.1016/j.iac.2021.07.002. Immunol Allergy Clin North Am. 2021. PMID: 34602231 Review.
2,003 results